Posts

Showing posts from August, 2020

RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue US Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy - BioSpace

RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue US Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy    BioSpace

RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue US Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy - BioSpace

RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue US Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy    BioSpace

IDEXX receives UK Acceptance for Legionella pneumophila testing - Cleanroom Technology

IDEXX receives UK Acceptance for Legionella pneumophila testing    Cleanroom Technology

RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue US Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy - BioSpace

RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue US Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy    BioSpace

LG's Advanced Refrigerators Deliver Smarter Culinary Life and More Hygienic Food Management - WebWire

LG's Advanced Refrigerators Deliver Smarter Culinary Life and More Hygienic Food Management    WebWire

Hospital-Treated Gram-Negative Infections Market Structure Analysis for the Period 2016 – 2024 - thedailychronicle.in

Hospital-Treated Gram-Negative Infections Market Structure Analysis for the Period 2016 – 2024    thedailychronicle.in

A Clinical Study on the Use of Intraventricular Polymyxin B Supplement | IDR - Dove Medical Press

A Clinical Study on the Use of Intraventricular Polymyxin B Supplement | IDR    Dove Medical Press

Other news to note for Aug. 25, 2020 | 2020-08-25 - BioWorld Online

Other news to note for Aug. 25, 2020 | 2020-08-25    BioWorld Online

Entasis Therapeutics Announces $25 Million Private Placement - StreetInsider.com

Entasis Therapeutics Announces $25 Million Private Placement    StreetInsider.com

A Clinical Study on the Use of Intraventricular Polymyxin B Supplement | IDR - Dove Medical Press

A Clinical Study on the Use of Intraventricular Polymyxin B Supplement | IDR    Dove Medical Press

Other news to note for Aug. 25, 2020 | 2020-08-25 - BioWorld Online

Other news to note for Aug. 25, 2020 | 2020-08-25    BioWorld Online

Hospital Acquired Infections Treatment Market Size, Demand, Analysis, Revenue and Forecast 2025 - The Daily Chronicle

Hospital Acquired Infections Treatment Market Size, Demand, Analysis, Revenue and Forecast 2025    The Daily Chronicle

Hospital Acquired Infections Treatment Market Size, Demand, Analysis, Revenue and Forecast 2025 - The Daily Chronicle

Hospital Acquired Infections Treatment Market Size, Demand, Analysis, Revenue and Forecast 2025    The Daily Chronicle

New approaches to gram-negative infections: A look at the pipeline - Healio

New approaches to gram-negative infections: A look at the pipeline    Healio

Bio-based communication networks could control cells in the body to treat conditions - EurekAlert

Bio-based communication networks could control cells in the body to treat conditions    EurekAlert

Woman receives double lung transplant during pandemic - The Herald Review

Woman receives double lung transplant during pandemic    The Herald Review

Ecolab Synergex™ Sanitizer & Disinfectant First to Receive U.S. EPA Biofilm Claim - Business Wire

Ecolab Synergex™ Sanitizer & Disinfectant First to Receive U.S. EPA Biofilm Claim    Business Wire

CFRX: Enrollment Continues in Phase 3 Trial of Exebacase… - Zacks Small Cap Research

CFRX: Enrollment Continues in Phase 3 Trial of Exebacase…    Zacks Small Cap Research

Pseudomonas Aeruginosa Infection Treatment Market Size and Growth By Leading Vendors, By Types and Application, By End Users and Forecast to 2027 - Bulletin Line

Pseudomonas Aeruginosa Infection Treatment Market Size and Growth By Leading Vendors, By Types and Application, By End Users and Forecast to 2027    Bulletin Line

Bio-based communication networks could control cells in the body to treat conditions - EurekAlert

Bio-based communication networks could control cells in the body to treat conditions    EurekAlert

Architecture and function of human uromodulin filaments in urinary tract infections - Science Magazine

Architecture and function of human uromodulin filaments in urinary tract infections    Science Magazine

A novel mouse model of chronic suppurative otitis media and its use in preclinical antibiotic evaluation - Science Advances

A novel mouse model of chronic suppurative otitis media and its use in preclinical antibiotic evaluation    Science Advances

Acute Bacterial Skin and Skin Structure Infections Market Insights, Epidemiology, and Market Forecast By DelveInsight - Bulletin Line

Acute Bacterial Skin and Skin Structure Infections Market Insights, Epidemiology, and Market Forecast By DelveInsight    Bulletin Line

ContraFect Reports Second Quarter 2020 Financial Results and Provides Business Update - Stockhouse

ContraFect Reports Second Quarter 2020 Financial Results and Provides Business Update    Stockhouse

Global Bacterial Biopesticides Market Global Trends Survey 2020 to 2026 and Industry Growth Report - Bulletin Line

Global Bacterial Biopesticides Market Global Trends Survey 2020 to 2026 and Industry Growth Report    Bulletin Line

Bacteria's secret weapon revealed - Science Daily

Bacteria's secret weapon revealed    Science Daily

Self-targeting, zwitterionic micellar dispersants enhance antibiotic killing of infectious biofilms—An intravital imaging study in mice - Science Advances

Self-targeting, zwitterionic micellar dispersants enhance antibiotic killing of infectious biofilms—An intravital imaging study in mice    Science Advances

Aridis Pharmaceuticals Announces Second Quarter 2020 Results - PRNewswire

Aridis Pharmaceuticals Announces Second Quarter 2020 Results    PRNewswire

Armata Pharmaceuticals Announces Second Quarter 2020 Results and Provides General Corporate Update - BioSpace

Armata Pharmaceuticals Announces Second Quarter 2020 Results and Provides General Corporate Update    BioSpace

MicuRx Announces CARB-X US$7.78 Million Funding for Development of MRX-8 - BioSpace

MicuRx Announces CARB-X US$7.78 Million Funding for Development of MRX-8    BioSpace

Accelerating Antimicrobial Stewardship Interventions Using the PhenoTest System for Gram-Negative Bacteremia: Data on Real-World... - Contagionlive.com

Accelerating Antimicrobial Stewardship Interventions Using the PhenoTest System for Gram-Negative Bacteremia: Data on Real-World...    Contagionlive.com

MicuRx Announces CARB-X US$7.78 Million Funding for Development of MRX-8 - PRNewswire

MicuRx Announces CARB-X US$7.78 Million Funding for Development of MRX-8    PRNewswire

Distribution and Molecular Characterization of Resistance Gene Cassett | IDR - Dove Medical Press

Distribution and Molecular Characterization of Resistance Gene Cassett | IDR    Dove Medical Press

Aridis Pharmaceuticals Announces Second Quarter 2020 Results | News - WFMZ Allentown

Aridis Pharmaceuticals Announces Second Quarter 2020 Results | News    WFMZ Allentown

How to keep your contact lenses clean (and what can go wrong if you don't) - The Conversation AU

How to keep your contact lenses clean (and what can go wrong if you don't)    The Conversation AU

Why You Need to Keep Your Contact Lenses Clean - Lifehacker Australia

Why You Need to Keep Your Contact Lenses Clean    Lifehacker Australia

Aridis Pharmaceuticals Announces Second Quarter 2020 Results - PRNewswire

Aridis Pharmaceuticals Announces Second Quarter 2020 Results    PRNewswire

Structure of the essential inner membrane lipopolysaccharide–PbgA complex - Nature.com

Structure of the essential inner membrane lipopolysaccharide–PbgA complex    Nature.com

How to keep your contact lenses clean (and what can go wrong if you don't) - The Conversation AU

How to keep your contact lenses clean (and what can go wrong if you don't)    The Conversation AU

Why You Need to Keep Your Contact Lenses Clean - Lifehacker Australia

Why You Need to Keep Your Contact Lenses Clean    Lifehacker Australia

RedHill Biopharma’s Phase 2/3 COVID-19 Study Approved in Mexico - Yahoo Finance

RedHill Biopharma’s Phase 2/3 COVID-19 Study Approved in Mexico    Yahoo Finance

Deprived of oxygen, layers of bacteria get creative - Phys.org

Deprived of oxygen, layers of bacteria get creative    Phys.org

Stewardship / Resistance Scan for Aug 07, 2020 | CIDRAP - CIDRAP

Stewardship / Resistance Scan for Aug 07, 2020 | CIDRAP    CIDRAP

How to keep your contact lenses clean (and what can go wrong if you don't) - Medical Xpress

How to keep your contact lenses clean (and what can go wrong if you don't)    Medical Xpress

Rapid and robust evolution of collateral sensitivity in Pseudomonas aeruginosa antibiotic-resistant mutants - Science Advances

Rapid and robust evolution of collateral sensitivity in Pseudomonas aeruginosa antibiotic-resistant mutants    Science Advances

Distribution and Molecular Characterization of Resistance Gene Cassett | IDR - Dove Medical Press

Distribution and Molecular Characterization of Resistance Gene Cassett | IDR    Dove Medical Press

Antibiotic Resistance Market is Increasing at a Healthy CAGR of 5.85% During Forecast to 2025 - My Amazon Echo

Antibiotic Resistance Market is Increasing at a Healthy CAGR of 5.85% During Forecast to 2025    My Amazon Echo

Entasis Therapeutics Reports Second Quarter 2020 Financial Results and Business Update - StreetInsider.com

Entasis Therapeutics Reports Second Quarter 2020 Financial Results and Business Update    StreetInsider.com

Anti-anaerobic therapy over-prescribed for patients with aspiration community-acquired pneumonia - 2 Minute Medicine

Anti-anaerobic therapy over-prescribed for patients with aspiration community-acquired pneumonia    2 Minute Medicine

Could Drug-Resistant Bacteria Cause The Next Pandemic? - Forbes

Could Drug-Resistant Bacteria Cause The Next Pandemic?    Forbes

Coordinating a neutrophil swarm - Science

Coordinating a neutrophil swarm    Science

RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico - GlobeNewswire

RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico    GlobeNewswire

How to keep your contact lenses clean (and what can go wrong if you don't) - Medical Xpress

How to keep your contact lenses clean (and what can go wrong if you don't)    Medical Xpress

Stewardship / Resistance Scan for Aug 07, 2020 | CIDRAP - CIDRAP

Stewardship / Resistance Scan for Aug 07, 2020 | CIDRAP    CIDRAP

Higher Prevalence of Oral Candida Fungus Found in CF Patients - Cystic Fibrosis News Today

Higher Prevalence of Oral Candida Fungus Found in CF Patients    Cystic Fibrosis News Today

Antibiotic-Resistant Bacteria and Sewage - News-Medical.net

Antibiotic-Resistant Bacteria and Sewage    News-Medical.net

RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico - GlobeNewswire

RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico    GlobeNewswire

Fighting for a life unlimited with the Cystic Fibrosis Trust - Health Europa

Fighting for a life unlimited with the Cystic Fibrosis Trust    Health Europa

How to keep your contact lenses clean (and what can go wrong if you don't) - The Conversation AU

How to keep your contact lenses clean (and what can go wrong if you don't)    The Conversation AU

Why You Need to Keep Your Contact Lenses Clean - Lifehacker Australia

Why You Need to Keep Your Contact Lenses Clean    Lifehacker Australia

RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico - GlobeNewswire

RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico    GlobeNewswire

Entasis Therapeutics Reports Second Quarter 2020 Financial Results and Business Update - GlobeNewswire

Entasis Therapeutics Reports Second Quarter 2020 Financial Results and Business Update    GlobeNewswire

RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico - GlobeNewswire

RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico    GlobeNewswire

RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico - GlobeNewswire

RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico    GlobeNewswire

RedHill Biopharma Initiates Global Phase 2/3 Study for COVID-19 - BioSpace

RedHill Biopharma Initiates Global Phase 2/3 Study for COVID-19    BioSpace

Medieval medicine to tackle antibiotic resistance - News-Medical.Net

Medieval medicine to tackle antibiotic resistance    News-Medical.Net

Gram-Negative Bacterial Infection Market Segmentation Detailed Study with Forecast to 2025 - Bulletin Line

Gram-Negative Bacterial Infection Market Segmentation Detailed Study with Forecast to 2025    Bulletin Line

Gram-Negative Bacterial Infection Market Segmentation Detailed Study with Forecast to 2025 - Bulletin Line

Gram-Negative Bacterial Infection Market Segmentation Detailed Study with Forecast to 2025    Bulletin Line

Gram-Negative Bacterial Infection Market Segmentation Detailed Study with Forecast to 2025 - Bulletin Line

Gram-Negative Bacterial Infection Market Segmentation Detailed Study with Forecast to 2025    Bulletin Line

These 3 Charts Clearly Tell the Q2 Earnings Season Story - Nasdaq

These 3 Charts Clearly Tell the Q2 Earnings Season Story    Nasdaq

Virtu Financial (VIRT) Earnings Expected to Grow: Should You Buy? - Nasdaq

Virtu Financial (VIRT) Earnings Expected to Grow: Should You Buy?    Nasdaq